HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B V L Potter Selected Research

2- methoxyestradiol- 3,17- bis- O,O- sulfamate

5/20042-MeOE2bisMATE induces caspase-dependent apoptosis in CAL51 breast cancer cells and overcomes resistance to TRAIL via cooperative activation of caspases.
9/2003Steroid sulphatase inhibitors for breast cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B V L Potter Research Topics

Disease

14Neoplasms (Cancer)
07/2014 - 08/2003
13Breast Neoplasms (Breast Cancer)
07/2014 - 02/2003
2Prostatic Neoplasms (Prostate Cancer)
12/2008 - 12/2007
1Ovarian Neoplasms (Ovarian Cancer)
02/2009
1Hypoxia (Hypoxemia)
12/2008
1Endometriosis
02/2008
1Choristoma (Ectopic Tissue)
02/2008
1Lymphoma (Lymphomas)
10/2006
1Pathologic Processes
04/2005
1X-Linked Ichthyosis (Ichthyosis, X Linked)
04/2005
1Choriocarcinoma
02/2005

Drug/Important Bio-Agent (IBA)

4Hormones (Hormone)IBA
05/2008 - 09/2003
4Steryl-Sulfatase (Steroid Sulfatase)IBA
05/2008 - 09/2003
32- methoxyestradiol- 3,17- O,O- bis(sulfamate)IBA
02/2009 - 12/2007
2taxaneIBA
07/2014 - 01/2010
22-ethyloestradiol-bis-sulfamateIBA
11/2008 - 02/2003
2Aromatase (CYP19)IBA
02/2008 - 02/2005
2irosustatIBA
02/2008 - 04/2005
2CytokinesIBA
10/2006 - 02/2005
2Dihydrotachysterol (AT 10)IBA
03/2006 - 02/2005
22- methoxyestradiol- 3,17- bis- O,O- sulfamateIBA
05/2004 - 09/2003
22-MethoxyestradiolIBA
02/2004 - 02/2003
2Pharmaceutical PreparationsIBA
09/2003 - 02/2003
12- (3,4,5- trimethoxybenzyl)- 6- O- sulphamoyl- 7- methoxy- 1,2,3,4- tetrahydroisoquinolineIBA
07/2014
1ColchicineFDA LinkGeneric
01/2010
1TubulinIBA
01/2010
12-O-benzylinositol 1,3,4,5,6-pentakisphosphateIBA
01/2010
1MTOR InhibitorsIBA
01/2010
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2010
1Proteins (Proteins, Gene)FDA Link
02/2009
1Deoxyglucose (2 Deoxy D glucose)IBA
12/2008
1Drug CombinationsIBA
12/2008
1Angiogenesis InhibitorsIBA
11/2008
1AndrogensIBA
05/2008
1Estrogens (Estrogen)FDA Link
02/2008
12- methoxy- 3- O- sulfamoyl- 17- cyanomethylestra- 1,3,5(10)- trieneIBA
12/2007
1Taxoids (Taxanes)IBA
12/2007
1HypoxanthineIBA
10/2006
1diphosphoric acid (pyrophosphoric acid)IBA
10/2006
13 (or 17)-beta-hydroxysteroid dehydrogenaseIBA
03/2006
1Estradiol (Delestrogen)FDA LinkGeneric
04/2005
1EnzymesIBA
04/2005
1estrone sulfate (Evex)FDA Link
04/2005
1AndrostenediolIBA
04/2005
1SteroidsIBA
04/2005
1Dehydroepiandrosterone SulfateIBA
04/2005
1EstroneFDA Link
04/2005
1Dehydroepiandrosterone (DHEA)IBA
04/2005
12-methoxyoestrone-3-O-sulphamateIBA
02/2005
1tiboloneIBA
02/2005
1Caspase 8 (Caspase-8)IBA
05/2004
1Caspase 3 (Caspase-3)IBA
05/2004
1CaspasesIBA
05/2004
1Aromatase InhibitorsIBA
09/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2003
1CollagenIBA
02/2003
12-methoxyestriolIBA
02/2003
1matrigelIBA
02/2003
1PlasticsIBA
02/2003

Therapy/Procedure

5Therapeutics
12/2008 - 09/2003